Carisma Therapeutics to Present at Upcoming Conferences

Rhea-AI Summary

Carisma Therapeutics (Nasdaq: CARM), a clinical-stage biopharmaceutical company, has announced its participation in four upcoming healthcare conferences. Steven Kelly, President and CEO, will represent the company at these events:

1. Baird 2024 Global Healthcare Conference on September 10 at 12:50 PM ET in New York, NY
2. H.C. Wainwright 26th Annual Global Investment Conference on September 11 at 1:30 PM ET in New York, NY
3. Chardan's 8th Annual Genetic Medicines Conference on September 30 at 4:00 PM ET in New York, NY
4. The Cell & Gene Meeting on the Mesa on October 7 at 9:30 AM MST in Phoenix, AZ

Live webcasts of these presentations will be available on Carisma's Investor Events webpage, with replays archived for a time after each event.

PHILADELPHIA, Sept. 3, 2024 /PRNewswire/ -- Carisma Therapeutics Inc. (Nasdaq: CARM) ("Carisma" or the "Company"), a clinical-stage biopharmaceutical company focused on discovering and developing innovative immunotherapies, today announced that Steven Kelly, President and Chief Executive Officer, will participate in the following upcoming conferences:

Baird 2024 Global Healthcare Conference

• Tuesday, September 10 at 12:50 PM ET
• New York, NY

H.C. Wainwright 26^th Annual Global Investment Conference

• Wednesday, September 11 at 1:30 PM ET
• New York, NY

Chardan's 8^th Annual Genetic Medicines Conference

• Monday, September 30 at 4:00 PM ET
• New York, NY

The Cell & Gene Meeting on the Mesa

• Monday, October 7 at 9:30 AM MST
• Phoenix, AZ

Live webcasts will be available on the Company's Investor Events webpage. A replay of the webcasts, when available, will be archived for a limited time following the event.

About Carisma

Carisma Therapeutics Inc. is a clinical-stage biopharmaceutical company focused on utilizing our proprietary macrophage and monocyte cell engineering platform to develop transformative immunotherapies to treat cancer and other serious diseases. We have created a comprehensive, differentiated proprietary cell therapy platform focused on engineered macrophages and monocytes, cells that play a crucial role in both the innate and adaptive immune response. Carisma is headquartered in Philadelphia, PA. For more information, please visit www.carismatx.com.

Investors:
Shveta Dighe
Head of Investor Relations
investors@carismatx.com

Media Contact:
Julia Stern
(763) 350-5223
jstern@realchemistry.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/carisma-therapeutics-to-present-at-upcoming-conferences-302235237.html

SOURCE Carisma Therapeutics Inc.

FAQ

What conferences will Carisma Therapeutics (CARM) attend in September and October 2024?

Carisma Therapeutics will attend four conferences: Baird Global Healthcare Conference (Sept. 10), H.C. Wainwright Global Investment Conference (Sept. 11), Chardan's Genetic Medicines Conference (Sept. 30), and The Cell & Gene Meeting on the Mesa (Oct. 7).

Who will represent Carisma Therapeutics (CARM) at the upcoming conferences?

Steven Kelly, President and Chief Executive Officer of Carisma Therapeutics, will represent the company at the upcoming conferences.

Where can investors watch Carisma Therapeutics' (CARM) conference presentations?

Live webcasts of Carisma Therapeutics' conference presentations will be available on the Company's Investor Events webpage. Replays will be archived for a time following each event.

What is the date and time of Carisma Therapeutics' (CARM) presentation at the Baird 2024 Global Healthcare Conference?

Carisma Therapeutics will present at the Baird 2024 Global Healthcare Conference on Tuesday, September 10 at 12:50 PM ET in New York, NY.